{
  "id": "5c8857e975a4a5d219000009",
  "type": "yesno",
  "question": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?",
  "ideal_answer": "Yes, apoE mimetics are being considered as a treatment against Alzheimer's disease, and  they have been shown to protect AD mouse models against these AD-like features.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22965147"
  ],
  "snippets": [
    {
      "text": "The apolipoprotein-E-mimetic COG112 protects amyloid precursor protein intracellular domain-overexpressing animals from Alzheimer's disease-like pathological features.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22965147",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Studies show that administration of apolipoprotein E (apoE) and apoE-derived small peptide mimetics protect AD mouse models against these AD-like features.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22965147",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}